313 related articles for article (PubMed ID: 20043329)
1. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
[TBL] [Abstract][Full Text] [Related]
2. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
[TBL] [Abstract][Full Text] [Related]
3. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
[TBL] [Abstract][Full Text] [Related]
4. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Panou FK; Kotseroglou VK; Lakoumentas JA; Chrysanthopoulou SA; Armeniakos JA; Stratigou T; Veve H; Zacharoulis AA
Hellenic J Cardiol; 2006; 47(6):344-51. PubMed ID: 17243506
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.
Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yamanaka S; Iiyama T; Kumagai N; Furuno T; Sugiura T; Kitaoka H
BMC Cardiovasc Disord; 2015 Jun; 15():53. PubMed ID: 26077897
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
[TBL] [Abstract][Full Text] [Related]
8. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
[TBL] [Abstract][Full Text] [Related]
10. Assessment of left ventricular systolic function in hypertrophic cardiomyopathy patients with myocardial injury: a study based on layer-specific speckle tracking echocardiaography.
Liu W; Zhang Y; Liu Y; Ma C; Yang J; Sun D
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2129-2137. PubMed ID: 32602022
[TBL] [Abstract][Full Text] [Related]
11. Significance and Determinants of Cardiac Troponin I in Patients With Obstructive Hypertrophic Cardiomyopathy.
Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Yang C; Qiao S
Am J Cardiol; 2015 Dec; 116(11):1744-51. PubMed ID: 26434514
[TBL] [Abstract][Full Text] [Related]
12. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
[TBL] [Abstract][Full Text] [Related]
13. Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy.
Minoshima M; Noda A; Nishizawa T; Hara Y; Sugiura M; Iino S; Nagata K; Koike Y; Murohara T
Circ J; 2009 Dec; 73(12):2294-9. PubMed ID: 19838000
[TBL] [Abstract][Full Text] [Related]
14. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
[TBL] [Abstract][Full Text] [Related]
16. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
18. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
19. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
